Alignment HealthcareALHC.OValuation Analysis

As of Oct 16, 2026, Alignment Healthcare (ALHC.O) trades at a P/E of 42.20x, P/B of 6.50x, P/S of 0.38x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 14th percentile over the trailing 10Y window (vs. 14th percentile over 3Y); P/B sits at the 24th percentile over the trailing 10Y window (vs. 12th percentile over 3Y); P/S sits at the 1st percentile over the trailing 10Y window (vs. 2nd percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 81st percentile within its industry and the 81st percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
Cross-checking P/E against P/B, the two percentiles sit within 9.9 points of each other — a consistent signal from both angles. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Alignment Healthcare operates in the Finance, Insurance, And Real Estate sector. Data refreshes weekly and is for reference only, not investment advice.